Difference between revisions of "Journal Club"
From Bioinformatics Lab
Line 11: | Line 11: | ||
|style="padding:.4em;"|JE Shim | |style="padding:.4em;"|JE Shim | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
− | [// | + | [//pubmed.gov/27851969 Epigenomic Deconvolution of Breast Tumors Reveals Metabolic Coupling between Constituent Cell Types.] |
|- | |- | ||
|style="padding:.4em;" rowspan=2|2017/02/21 | |style="padding:.4em;" rowspan=2|2017/02/21 | ||
Line 17: | Line 17: | ||
|style="padding:.4em;"|EB Kim | |style="padding:.4em;"|EB Kim | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
− | [//biorxiv.org/content/early/2016/12/30/097451 Convergence of dispersed regulatory mutations predicts driver genes in prostate cancer.] | + | [http://biorxiv.org/content/early/2016/12/30/097451 Convergence of dispersed regulatory mutations predicts driver genes in prostate cancer.] |
|- | |- | ||
|style="padding:.4em;"|17-09 | |style="padding:.4em;"|17-09 | ||
|style="padding:.4em;"|EB Kim | |style="padding:.4em;"|EB Kim | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
− | [// | + | [//pubmed.gov/27723759 Chromatin structure-based prediction of recurrent noncoding mutations in cancer.] |
|- | |- | ||
|style="padding:.4em;" rowspan=2|2017/02/07 | |style="padding:.4em;" rowspan=2|2017/02/07 | ||
Line 28: | Line 28: | ||
|style="padding:.4em;"|DS Bae | |style="padding:.4em;"|DS Bae | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
− | [//biorxiv.org/content/early/2016/11/17/088286 Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade.] | + | [http://biorxiv.org/content/early/2016/11/17/088286 Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade.] |
|- | |- | ||
|style="padding:.4em;"|17-07 | |style="padding:.4em;"|17-07 | ||
|style="padding:.4em;"|MY Lee | |style="padding:.4em;"|MY Lee | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
− | [//biorxiv.org/content/early/2016/11/28/090134 Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer.] | + | [http://biorxiv.org/content/early/2016/11/28/090134 Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer.] |
|- | |- | ||
|style="padding:.4em;" rowspan=1|2017/01/31 | |style="padding:.4em;" rowspan=1|2017/01/31 |
Revision as of 09:53, 10 February 2017
2012
2011
2010